ClinicalTrials.govpublic full text
Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma
renal cell carcinoma, mrcc, sunitinib, bevacizumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 868529
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.